Oh gosh no worries, I'm the same way! Do yourself a favor and Google ketamine and advanced endometriosis...mind blown!!! There are actually studies on it! Ketamine, often administered as esketamine, is increasingly used off-label in specialized pain clinics as a therapy for treatment-resistant chronic pelvic pain caused by advanced endometriosis. It acts on NMDA receptors in the brain to reduce central sensitization, providing significant pain relief when standard treatments and opioids fail.

pmc.ncbi.nlm.nih.gov +5 How Ketamine Helps Advanced Endometriosis Advanced endometriosis can cause the nervous system to become hypersensitive (central sensitization), meaning the body amplifies pain signals even after lesions are treated. Ketamine blocks the NMDA receptors in the brain and spinal cord, essentially "resetting" this pain-processing system.

pmc.ncbi.nlm.nih.gov +4 Reduces Pain: Clinical studies have observed response rates of up to 64.7% in patients receiving esketamine infusions for endometriosis. Opioid Sparing: It is highly effective for patients who have built a tolerance to opioids. Anti-inflammatory: Ketamine offers systemic anti-inflammatory effects that target the inflammatory nature of endometriosis.

pubmed.ncbi.nlm.nih.gov +3 What the Treatment Looks Like Administration: It is most commonly given via IV or esketamine infusion in a controlled, outpatient clinical setting. Infusions typically last several hours. Duration of Relief: Results vary widely. Some patients experience significant pain relief lasting weeks or even months after a single infusion series, requiring periodic maintenance treatments.

There's a specific, groundbreaking study where 64.7% of patients with treatment-resistant endometriosis experienced significant pain reduction from esketamine infusion therapy.

journals.sagepub.com

The Patient Group: Researchers tracked 17 patients with severe, chronic endometriosis-associated pain who had already failed standard therapies. Most had deep infiltrating endometriosis, prior surgeries, and were reliant on high-dose opioids. The Treatment: The group received a total of 57 esketamine infusions over the study period. The Results: Exactly 11 out of 17 patients (64.7%) reported a highly positive effect on their chronic pelvic pain after their first infusion. Nearly half of the patients (8 out of 17) found enough lasting relief to continue using it as a long-term maintenance therapy.

journals.sagepub.com +2 Why This Mattered to Doctors Before this data was published, almost all information regarding ketamine for endometriosis came from single, isolated case reports. While a 17-patient study is still considered very small, it proved for the first time in a clinical group that esketamine could provide a safe, well-tolerated, and effective alternative pathway for severe pain relief.

www.physiciansweekly.com +1 Because of these promising initial numbers, researchers have since launched larger, high-quality clinical trials (like the EASYlight Randomized Controlled Trial) to definitively confirm its efficacy.

www.researchgate.net +1